We use both our own and third-party cookies for statistical purposes and to improve our services. If you continue to browse, we consider that you accept the use of these.

Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrism

By Barbara Stephenson

Posted July 19, 2019

Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrism

SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) — Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today that its laboratory has successfully [...]

By Barbara Stephenson

Posted October 3, 2018

CAP RNA-Seq

1 2 3 4

page 1 of 4

Start typing and press Enter to search